key: cord-0788875-p9vl7so1 authors: Sabbih, Godfred O.; Korsah, Maame A.; Jeevanandam, Jaison; Danquah, Michael K. title: Biophysical analysis of SARS‐CoV‐2 transmission and theranostic development via N protein computational characterization date: 2020-10-29 journal: Biotechnol Prog DOI: 10.1002/btpr.3096 sha: d3feaef7211572e75be1b079713b71235253c62b doc_id: 788875 cord_uid: p9vl7so1 Recently, SARS‐CoV‐2 has been identified as the causative factor of viral infection called Covid‐19, that belongs to the zoonotic beta coronavirus family known to cause respiratory disorders or viral pneumonia, followed by an extensive attack on organs that express angiotensin‐converting enzyme II (ACE2). Human transmission of this virus occurs via respiratory droplets from symptomatic and asymptomatic patients, that are released into the environment after sneezing or coughing. These droplets are capable of staying in the air as aerosols or surfaces and can be transmitted to persons through inhalation or contact with contaminated surfaces. Thus, there is an urgent need for advanced theranostic solutions to control the spread of Covid‐19 infection. The development of such fit‐for‐purpose technologies hinges on a proper understanding of the transmission, incubation and structural characteristics of the virus in the external environment as well as within the host. Hence, this article describes the development of an intrinsic model to describe the incubation characteristics of the virus under varying environmental factors. It also discusses on the evaluation of SARS‐CoV‐2 structural nucleocapsid protein properties via computational approaches to generate high‐affinity binding probes for effective diagnosis and targeted treatment applications by specific targeting of viruses. In addition, this article provides useful insights on the transmission behavior of the virus and create new opportunities for theranostics development. In the first quarter of the year 2020, World Health Organization (WHO) declared Covid-19 infection as a global pandemic due to its rapid spread across countries, increasing 13-fold outside of China in the first two weeks before the announcement (WHO virtual press conference on Covid-19, 11 March 2020). Covid-19 infection is caused by SARS-CoV-2, which is a viral strain belonging to the family Coronaviridae and genus Betacoronavirus. Other subfamily members, include alpha, gamma and delta coronaviruses with the alpha and beta coronaviruses infecting only mammals, usually causing respiratory illness, gastroenteritis in other animals, and extensive attacks on organs that express angiotensin-converting enzyme II (ACE2), such as the heart, liver, testis, kidney, and intestines 1-4 . Betacoronaviruses have four distinct lineages, that are identified and designated from A to D based on the amino acid (AA) sequence alignment analysis, and SARS-CoV-2 belongs to lineage C. Further, members of this family share common characteristics, such as a unimolecular, positive-stranded RNA genome, an RNA-binding nucleocapsid protein (N), a homo-trimeric spike protein (S), an outer membrane glycoproteins (M), and a small pentameric membrane protein called the envelope protein (E) 5 . SARS-CoV-2 is the latest of the two previously identified zoonotic coronaviruses, such as SARS-CoV and MERS-CoV, that are belonging to the beta-subfamily. Recent phylogenetic analysis showed that SARS-CoV-2 is about 88% identical to two bat-derived SARS-like coronaviruses (bat-SLCoVZC45 and bat-SL-CoVZXC21), about 50% identical to MERS-CoV, and about 79% identical to SARS-CoV 6, 7 . SARS-CoV-2 transmission occurs through the release of respiratory droplets from symptomatic and asymptomatic patients after sneezing or coughing into the environment. These droplets are aerosollike and capable of staying in the air or surfaces for an extended period and can be transmitted to persons through inhalation or contact with contaminated surfaces 8 . The virus makes its way through the eyes, nose or mouth and attaches itself to the mucous membrane for incubation, multiplies and then reaches the pulmonary system as well as other body organs, that have a high percentage of ACE2, especially in the lower respiratory system 9 . The virus begins its life cycle when the spike protein binds to the ACE2 cellular receptor, after which conformational changes in the spike protein promotes viral fusion through the endosomal pathway. Although the exact incubation period of the virus is unknown, current reported research indicates a range of about 2.1 days to 24 days 10 upon contact with an infected person. Furthermore, SARS-CoV-2 releases its RNA into the host cell followed by translation of the genome RNA open reading frames 1ab (ORF1ab) into viral replicase polyproteins (pp1a and 1ab), which are then cleaved by viral proteinases 5 . The polymerase produces mRNAs, which are later translated into relevant proteins. These viral proteins and the genomic RNA are assembled into virions and released out of the host cell via vesicles 3, 11 . The same pathway is observed for SARS-CoV 7 . However, SARS-CoV possesses a lower binding affinity to ACE2. This higher binding affinity of SARS-CoV-2 is attributed to a unique ACE2-interacting residue (Lys417), which increases the affinity via the formation of salt-bridge interactions, with ACE2 contributing to an overall positive surface potential of S protein which further increases the binding affinity 12 Mathematical models that characterize these viral attributes with high precision will aid in decision-making, such as better healthcare interventions. Li et al. (2020) developed a numerical model that describes the spatiotemporal elements of infections among 375 Chinese urban areas and explored measures which slows down the spread of SARS-CoV-2 13 . Several transmission models, based on the basic Susceptible-Infected-Recovered (SIR) compartmental model, have been proposed to investigate and estimate the transmission dynamics of SARS-CoV-2 [13] [14] [15] . For example, based on the model, initially reported estimates of the basic reproductive number, R 0 has been reviewed to acquire precise estimates of the spread 11 . They reported the estimated mean of the basic reproduction number, R 0 for SARS-CoV-2 as approximately 3.28, which is higher than the estimate provided by the WHO (R 0 ~1.95). Thus, the study concluded that the differences in the estimates may have resulted from insufficient data and the short onset time available for the calculation of the previous estimate. Also, a significant number of transmission models are based on SEIR compartmental model which represents the flow of individuals in the Susceptible, Exposed, Infected, and Recovered compartments. The SEIR model has been utilized to investigate the adequacy of quarantine and social distance mediations, whilst others have changed the model to discover analytical and numerical results to demonstrate that SARS-CoV-2 would stay endemic 15, 16 . Most of the current models developed assume post-infection immunity, thus, the SEIR model is highly beneficial in the prediction of effective lockdown measures and immunity among patients after infection. Though, certain clinical diagnosis and model studies suggest that immunity gained after recovery may be short-lived and reinfection may occur within a year, there is currently limited evidence to support post-infection immunity 17 . In the analysis presented in this article, we assume the non-existence of post-infection immunity and introduced the SEIS (Susceptible-Exposed-Infected-Susceptible) compartmental model. This model mimics the SEIR model except that individuals are moved back to the susceptible compartment after recovery, and this is important to understand the dynamics of transmission at full scale. Further, the article discusses the structural characteristics of the SARS-CoV-2 N protein with RNA binding domains, and its role in interfering with the normal reproductive cycle of the host cell as well as participating in replication, transcription, and packaging of the viral genome 7, 18 . Unlike the other structural proteins, the N protein is highly conserved and has been shown to be mostly expressed at the initial stages of the viral infection 19 , serving as a significant target for the development of theranostics to identify and treat the infection in the early stage. Most epidemiological models are generated from the general deterministic SEIR model. This model comprises of four compartments, namely Susceptible, Exposed, Infected, and Recovered/Removed. Other models can be obtained from SEIR under certain parametric restrictions. In the limiting case where recovery from infection confers no immunity, the R compartment is removed resulting in the SEI or SEIS model. Here, the infected individual either return to being susceptible. This model is also used, when the average period of immunity approaches zero. The basic form of the SEIS model is the SIS model. However, the SEIS model assumes that an individual who is susceptible would initially be latent before getting infectious, unlike the SIS model, as shown in Where, λ denotes the population influx, µ is the natural death rate of individuals, β 1 , β 2 and β 3 are the constant transmission rates from infected persons (I), exposed individuals (E) and the concentration of virus in the environment (V), respectively. Further, ϒ is the recovery rate, ϵ -1 represents the incubation period of the virus, ω is the rate of death induced by infection, α 1 and α 2 is the host shedding rates from infected and exposed individuals, and σ is the rate at which the virus is removed through activities, such as sanitizing of infected items and surfaces. The parameters utilized in the model are assumed to be positive. R 0 is evaluated as ( −1 ) and indicates the spectral radius of FV -1 Let, Where, R a represents the direct transmission route for the exposed (exposed to susceptible), R b is the direct transmission route for the infected (infected to susceptible) and R c comes from the contribution from the indirect transmission route (environment to susceptible). The SEIS framework was first formulated in the study of the rabies population dynamics in fox 22 . Their results discussed certain quantitative measures for controlling rabies via culling or vaccinations. Further analysis and numerical simulations were conducted using Hopf bifurcation 23 . It is worthy to note that the SEIS models present periodic solutions from Hopf noise on the disease transmission rate assessment of the SEI model has been studied 26 . The deterministic R 0 and stochastic R 0 were found, and the asymptotic stability of the disease-free equilibrium was also analyzed. It was demonstrated, that in any event, when the deterministic basic reproductive number is R 0 < 1, epidemic could in any case develop due to the existence of disparities in the stochastic SEI model 26 [27] [28] [29] . In our quest to evaluate the SARS-CoV-2 viral replication rate, we have introduced a modified target cell-limited model. Here, we have assumed that at the rate of k, a SARS-CoV-2 virus (V) infects a susceptible or target cell (T) and the infected cell (I) produces new viruses at the rate of ρ as shown in Figure 2 . We also assume that infected cells could be cleared as a result of defense mechanisms from viral invasion as shown in Eqs. 11-13. = - Where, λ represents the production rate of new cells, µ is the apoptosis rate, δ is the infection induced cell death rate, and c is the rate at which viruses are cleared resulting from cell activities and properties, such as cytopathic effect. The basic reproduction number is obtained as in Eq. 14. Where, T 0 is the density of the pre-infected target cells. The target cell-limited framework was formulated from the knowledge that viral propagation is always constrained by the accessibility of target cells. Mathematical modeling of viral kinetics within host cells has broadened understanding of viral infection dynamics and has improved healthcare interventions. In modelling the 'within-host' viral kinetics of influenza, modifications such as considering an eclipse phase of infected cells as well as ignoring the target cell production and death rates were integrated into the basic target celllimited model. These modifications were based on the short duration of Influenza and the assumption that infected cells can support viral replication before they are cleared. The basic reproductive number, R 0 , was estimated to be 22, when their modified model was also used to study the viral kinetics of H1N1 virus 27 . Several models have been developed to investigate SARS-CoV-2 within the replication dynamics of the host cell 30 . Further, they also compared the infection time of the coronavirus to other viral infections, such as Ebola and Influenza, and identified that the infecting time of SARS-CoV-2 is 3 times much slower than Ebola and 60 times slower than Influenza 30 . In deriving an analytical solution for the fundamental target cell-limited framework by utilizing a quasi-steady-state approximation without cytopathic effect, it was discovered that the deduction of the solution is critically subjected to the non-cytopathic condition 29 . Depending on the innate immune controls and antiviral drug-induced defense mechanisms, certain target cells are cleared or inhibited as a result of viral invasion, and are not able to synthesize viral components 31, 32 . The SARS-CoV-2 target cell-limited model proposed in this article was formulated by introducing another parameter 'δ' into the infected cell compartment to account for the rate at which cells are cleared in the I-compartment for precise analytical results, since the analytical solutions of the viral kinetics model are dependent on the non-cytopathic effects 29 . Thus, the model can be applied to the statistical data available to probe the dynamic behavior and transmission of Covid-19. The The S protein is a large, homo-trimeric type I membrane glycoprotein of 1128-1472 amino acids. It is a fusion protein that mediates receptor binding and viral entry in the host cell, and is the main target for neutralization by the antibodies of the adaptive immune system in the host 5 . The S protein protrudes from the surface of the virus and interacts with the host cell via ACE2 33 . Each monomer of the S protein is about 180 kDa and have subunits, namely S1 and S2, folded as two separated units in the N-and C-terminal domains of the monomers as shown in Figure 4 . The S1 subunit contains an NTD (residues 14-305) , a RBD (residues 319-541), and two CTDs (residues 528-686) while the S2 subunit contains the FP (residues 788-806), FPPR (residues 834-910), HR1 (residues 912-984), CH (residues 985 -1035), CD (residues 1036 -1068), HR2 (residues 1163-1213), TM domain (1213-1237 residues), and the cytoplasmic domain (residues 1237-1273) 34, 35 . Either the N-and C-terminal domains can function as the receptor-binding region during interaction with the human ACE2 or the ACE2 of other mammals 5 . Hence, the S protein has gained significant attention in the antiviral drug development, due to its receptor-binding functionality 5 . with the N protein during viral replication via its carboxy-terminal 37 .The E protein is a small pentameric protein of about 10 kDa, which spreads uniformly in the lipid bi-layer with about 20 copies per viral particle. Although its precise function is unknown, studies showed that it serves as a cation-selective channel and also plays an essential role in the virion assembly and morphogenesis 5, 38 . The nucleocapsid SARS-CoV-2 protein is an RNA-binding phosphoprotein, that form a ribonucleoprotein complex with the viral RNA and is the core structure of the virus. It is expressed by a 1260 nt N gene located next to ORF8 (which encodes the ORF8 non-structural protein). The N protein participates in the synthesis and translation of viral RNA, exhibits RNA chaperone activity, and also acts as a type I interferon antagonist 5 , making it immunogenic. It is structurally divided into N terminal RNA binding domain (NTD), C-terminal dimerization domain (CTD), and the intrinsically-disordered central linker rich in Serine and arginine 19, 39 . It has been reported that the concentration of N protein in infected patients is usually higher than the other viral proteins 19, 40, 41 , implying that theranostic developmental efforts targeting the N protein are plausible. Currently, there exist abundant literature on the structural properties of the SARS-CoV N protein, but limited information on the structure of SARS-CoV-2 N protein, as expected. For instance, thermodynamic studies showed that the N protein of SARS-CoV is stable between pH 7 and 10, the maximum conformational stability is identified to be around pH 9, and the SARS-CoV N protein is observed to undergo irreversible thermal-induced denaturation 19 . Further, it has been reported that the N terminal domain (NTD) of SARS-CoV-2 N protein functions as its RNA binding domain 40 . Also, the authors predicted the druggable location of the NTD part of the protein using molecular dynamic simulations and revealed specific surface charge distributions that can aid in the discovery of drugs specifically targeting the RNA binding domain. Such therapeutic approaches will prevent the assembling of viral RNA by acting on the N protein of the virus to inhibit viral assembly and replication. Thus, this article discusses on the N protein as, besides being highly conserved and plays significant roles in RNA synthesis and translation, its concentrations in serum samples are high and detectable even after just a day of infection 5, 19 . These traits present an opportunity to develop diagnostic solutions for early detection as well as synthesizing antiviral agents that will potentially intercept viral replication. The N terminal domain of the coronavirus N protein is responsible for binding to the viral RNA, resulting in a viral ribonucleoprotein (vRNA) complex, that is essential for viral replication as shown in Figure 6 . Additionally, the C terminal domain (CTD) is responsible for oligomerization (forming k-mers) 39, 42 . Certain studies focusing on the NTD of N protein for drug development and discovery has been performed using information deposited in public protein databases 41, 43 . Recently, protein database (PDB) has received solved structures of the NTD of SARS-CoV-2, either in isolation or complexed with other molecules. Presently, there are three structures of the NTD protein of SARS-CoV-2 that have been solved by X-ray crystallography with IDs; 6M3M (2.7 Å) 44 , 6WKP (2.67 Å) 45 , 6VYO (1.7 Å) 46 . 6M3M represents the structure of the N-Terminal RNA binding domain with the highest resolution of 2.7Å above the 2.1 Å median resolution of X-ray diffraction structures deposited at PDB as of 2020 (https://www.rcsb.org/stats/distribution-resolution) and was reported along with the characterization of the RNA-binding N protein domains. 6VYO is currently the structure with the lowest resolution of 1.7 Å. However, unlike 6M3M, 6VYO and 6WKP have been deposited as a complex with two and four other smaller ligands respectively. Furthermore, 6VYO has the lowest R-factor of about 2.05, representing a high quality structure 47, 48 , and thus may be preferred during molecular docking and molecular dynamics simulations studies 40, 41, 49 . Lastly, researchers have used nuclear magnetic resonance (NMR) spectroscopy to study the structure of N-NTD and its interaction with RNA, and showed the existence of a net positive charge on the surface of the NTD as responsible for binding, showed that occupying the binding pocket of the mild type, homologous, coronavirus HCoV-OC43 N-NTD bond with a higher affinity ligand has hydrogen-bond-forming moieties, decreased the RNA-binding affinity of the N-protein, which is critical for the development of targeting agents 53 . In SARS-CoV-2, arginine residues, specifically Arg89, decrease the bond formation groups of the ligand core. The most abundant interactions of the N protein and RNA bases are the arginineguanosine interactions, which will lead to a decrement in the effects of Arg89 on the aromatic core of the ligand. In summary, agents with high hydrogen bond-forming moieties may increase the binding affinity for theranostic applications, to increase the binding efficacy for SARS-COV-2. The structure of a protein determines its functionality. There are several ways to determine the functions of proteins based on the concept of annotation-by-homology, where annotations from well-characterized homologous proteins are used to predict the functions of new proteins 54 . Two of such methods that can be potentially applied to compare the N proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV, are protein sequence alignments as shown in Figure 5 and structural alignments as displayed in Figure 6 . However, it can be noted that the knowledge about structural proteins of SARS CoV-2, including the N protein, are based on the previous SARS-CoV and other human coronaviruses studies. Protein sequence alignment is a relatively easy approach to compare proteins, where algorithms are used to align amino acid sequences to predict conserved regions and secondary structures. An example of these algorithms is BLAST, which was used to predict the percentage identity of the three coronaviruses in Table 1 . Using BLASTp for protein sequence alignment analysis of the N proteins from the three zoonotic viral strains (SARS-CoV-2, SARS-CoV, and MERS-CoV) showed that the N protein of SARS-CoV-2 is much related to that of SARS-CoV, than MERS-CoV with 92.5% identity between SARS-CoV-2 and SARS-CoV as shown in Table 1 using BLAST. Further analysis of the conserved sequence regions can be used to predict the potential binding/active sites as well as the residues at the protein structure core for secondary structure prediction, since these sites are generally known to be highly conserved in homologous protein families. Although amino acid sequence alignments offer several benefits as discussed, it is not as accurate as structural alignment 55 . Structural alignment considers the spatial homologous protein evolution of close and/or distant family functional site predictions to identify the similarities and differences between them as well as searching for similar structures that have less sequence alignment identity 56, 57 . Further, FATCAT server is an example of highly efficient tools, that are used for protein structure comparison. Its comparison algorithm showed hinges and internal arrangements in two protein structures 57 . It can be utilized after amino acid sequence alignment of the SARS-CoV-2 N protein, for instance, to identify proteins of similar structural characteristics and this can be beneficial in the design of inhibitors or binders for diagnostics. MD simulations are highly helpful to obtain high-affinity protein-ligand structures for theranostic applications 69 . For example, the correlation between the binding affinity of wild-type protein-ligand and mutated protein-ligand complexes has been investigated by predicting the effects of mutation on the protein-ligand complexes using MD simulations and local geometrical features 72 . The authors measured the feature differences between the wild-type protein-ligand and mutated protein-ligand complexes as a way to evaluate changes in binding affinity using several machine learning models. Other researchers have also shown the importance of MD simulations in lead optimization for several protein structures [73] [74] [75] . Generally, MD simulation experiments take one of two forms; one that probes the structural properties of the proteins in question as shown in Figure 8 or one that tests non-structural properties by mutating parts or whole structures 72 . Thus, it will be possible to discover new ligands with higher binding affinities or improve on existing ones for N protein binding by utilizing these two approaches. Since, the N protein is most expressed in the initial stage of SARS-CoV infection, it makes an attractive target for theranostics. MD probing of the N protein will not only be useful for theranostic applications but enable a better understanding of the SARS-CoV-2 activity. Currently, proposals for the use of the N protein as a diagnostic tool is primarily focused on two different strategies, such as development of antibodies for the N protein, and recombinant production of N protein for the detection of N-protein-specific antibodies 19 . These experimental approaches could be made more efficient through MD simulations. In a recent work, MD simulation was used as a part of four-step in silico procedure (molecular docking, binding free-energy prediction, pharmacokinetics, and drug-likeness prediction as well as MD simulations) to determine the affinity binding characteristics of the drug candidate called ZINC00003118440 (8-(2- hydroxyethyl) aminophylline), which is a synthetic derivative of the Theophylline drug known to act as a bronchodilator with antiviral properties as confirmed in the literature 76 which are already used as major components in antiretroviral drugs [78] [79] [80] [81] , can also be used in the design of drugs to inhibit SARS-CoV-2 by targeting N-NTD. In conclusion, in vitro assays using these drug candidates will be required to demonstrate the effectiveness of the methods and serve as a deciding factor to select specific bronchodilator for the treatment of Covid-19 infection. Machine learning algorithms are either supervised or unsupervised, where the supervised learning refers to algorithms, that use labeled data sets to make prediction/inferences and focuses more on data classification by approximating with high accuracy. Contrarily, unsupervised learning uses unlabeled data sets for clustering techniques 82 . Some of the algorithmic methods that have been developed and used in machine learning, includes neural networks, naive Bayes, instance-based learning, principal component analysis, and logistic regression. Machine learning methods have been used in biotechnology to recognize biosensing specific signal features. It has also been used to analyze molecular dynamics trajectory data for clustering of ensembles with similar conformations to be used in docking and virtual screening studies, as well as for dimensionality reductions to identify most relevant features in trajectories, that reduces noise, and to develop empirical MD force fields for simulations [83] [84] [85] [86] . The relevance of these two applicational areas is significant in the search for diagnostic methods to target N protein in SARS-CoV-2. Biomolecular simulation trajectories are inherently of high dimensions, and therefore present a challenge in developing insights from datasets, that are generated by MD simulations. By applying deep learning methods, it is possible to reduce the dimensionality, making it easier to predict essential underlying motions of complex biological processes. primarily utilized a type of auto-encoder architecture known as variational auto-encoder (VAE), which represents the output latent attributes of the encoder section as a probability distribution, allowing for the latent space sampling at any point to generate new outcomes that corresponds to the patterns found in the initial data. The method involves in the generation of contact matrices as shown in Figure 9 , where atoms are separated by ~8Å were considered, and the output (contact matrices) were fed as inputs in the CVAE to generate the VAE embeddings, that has a lower dimensional representation 87 . ML methods can also be used to develop empirical molecular dynamic force fields for MD simulations [88] [89] [90] [91] , where Deep Potential for Molecular Dynamics (DeePMD), which is a deep neural network model. This MD simulation model is based on a manybody potential and interatomic forces trained with ab initio data is of particular interest 92 in the development of DeePMD kit, which is a software library that simplifies the development of energy fields for MD simulations. Their ML approach, together with experimental methods, helped to discover poly-ADP-ribose polymerase 1 (PARP1) inhibitor called CVL218, as a potential drug candidate to treat Covid-19 infection. Additionally, the researchers performed molecular docking studies and showed that CVL218 binds favorably to the N-NTD protein of SARS-CoV-2, thus providing a possible mode of antiviral activity against SARS-CoV-2 95 . Besides, Google DeepMind's ALPHAFOLD deep learning system has also been utilized to predict the related protein structures of SARS-CoV-2 96 , providing valuable insights to develop vaccine and drug to combat Covid-19 infection. A computational pipeline for the development of a highly efficient bio-probe via RNA-binding domain of SARS-CoV-2 N protein is proposed as displayed in Figure 10 . The pipeline is primarily divided into three sections, such as MD simulation, clustering via machine learning, and molecular docking approach. In a typical process, the protein structure is retrieved from widely used databases, such as the Protein Databank and prepared for simulation and stability analysis using tools, namely Chemistry at Harvard Molecular Mechanics (CHARMM) force field 97 , PropKa (protonation state prediction) 98 , visual molecular dynamics (VMD) (for visualization and analysis) 36 and Nanoscale molecular dynamics (NAMD) (to perform the simulation) 99 . In the next stage, machine learning models are used to perform unsupervised learning or clustering of the trajectory information obtained from the MD simulations in order to select the most stable conformation of the proteins for molecular docking experiments. The molecular docking experiments also begin with the development of a potential ligand pool followed by the docking simulations. It can be noted that the ligand pool is built with molecules that may be sourced from databases, such as ZINC and PubChem. After the docking process, high affinity ligand-protein complexes are selected for further MD simulation and clustering, followed by wet lab experiments after successful simulations and modifications are performed in silico. . Figure 10 . Potential in silico pipeline for the design of high-affinity ligands for use in diagnostics strategies for SARS-CoV-2 Understanding the transmission dynamics of SARS-CoV-2 is one of the initial steps towards the deployment of intervention strategies for Covid-19 mitigation. The present article has discussed the development of an intrinsic model to describe the growth characteristics of the virus, and this provide relevant information to probe the transmission rate of the virus under various conditions. Computational approaches in the search for theranostic methods to combat against SARS-CoV-2 are highly useful. Molecular dynamics simulations and machine learning methods are amongst the efficient tools that facilitate the development of theranostics for new pathogens, such as SARS-CoV-2, providing opportunities to develop new and tailored biomedical technologies. Thus, the in silico methods for probing ligand-target interactions will play a key role in identifying and designing diagnostic and therapeutic strategies to mitigate viral infections in the future. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far Challenges and Opportunities to Develop Diagnostics and Therapeutic Interventions for Severe Acute Respiratory Syndrome-Corona Virus 2 (SARS-CoV-2) Family -Coronaviridae Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Molecular immune pathogenesis and diagnosis of COVID-19 Airborne transmission of SARS-CoV-2: The world should face the reality COVID-19: towards understanding of pathogenesis Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia The reproductive number of COVID-19 is higher compared to SARS coronavirus Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) SEI-model for transmission of Nipah virus Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions A mathematical model for the novel coronavirus epidemic in Wuhan COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses The sars-cov nucleocapsid protein: a protein with multifarious activities, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases Global stability of a multi-group SEI model A Mathematical Model for the Transmission of Corona Virus Disease (COVID-19) in Sudan Population dynamics of fox rabies in Europe Hopf bifurcation and stable limit cycle behavior in the spread of infectious disease, with special application to fox rabies Global stability of an SEI epidemic model with general contact rate A new idea on density function and covariance matrix analysis of a stochastic SEIS epidemic model with degenerate diffusion Global Stability of Nonlinear Stochastic SEI Epidemic Model with Fluctuations in Transmission Rate of Disease Viral kinetic modeling: state of the art Mathematical Analysis of Viral Replication Dynamics and Antiviral Treatment Strategies: From Basic Models to Age-Based Multi-Scale Modeling A Quasi-Steady-State Approximation to the Basic Target-Cell-Limited Viral Dynamics Model with a Non-Cytopathic Effect In-host Modelling of COVID-19 Kinetics in Humans Host resilience to emerging coronaviruses Cell death and infection: A double-edged sword for host and pathogen survival A pneumonia outbreak associated with a new coronavirus of probable bat origin Distinct conformational states of SARS-CoV-2 spike protein Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 VMD -Visual Molecular Dynamics Peptide Domain Involved in the Interaction between Membrane Protein and Nucleocapsid Protein of SARS-Associated Coronavirus SARS coronavirus E protein forms cation-selective ion channels Structure of the SARS Coronavirus Nucleocapsid Protein RNA-binding Dimerization Domain Suggests a Mechanism for Helical Packaging of Viral RNA Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites Biochemical characterization of SARS-CoV-2 nucleocapsid protein The coronavirus nucleocapsid is a multifunctional protein Modular organization of SARS coronavirus nucleocapsid protein Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites MMDB and VAST+: tracking structural similarities between macromolecular complexes. Nucleic acids research Investigation of N Terminal Domain of SARS CoV 2 Nucleocapsid Protein with Antiviral Compounds Based on Molecular Modeling Approach Insights on 3D Structures of Potential Drug-Targeting Proteins of SARS-CoV-2: Application of Cavity Search and M olecular Docking Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2 Molecular dynamics simulations and drug discovery Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein Biochemical characterization of SARS-CoV-2 nucleocapsid protein. Biochemical and biophysical research communications 2020. 52. Schr¨odinger, L., The PyMOL molecular graphics system Structural Basis for the Identification of the N-Terminal Domain of Coronavirus Nucleocapsid Protein as an Antiviral Target Computational Prediction of Functionally Important Regions in Proteins A Structurally-Validated Multiple Sequence Alignment of 497 Human Protein Kinase Domains FATCAT: a web server for flexible structure comparison and structure similarity searching Recent advances in lab-on-a-chip technologies for viral diagnosis Assay Techniques and Test Development for COVID-19 Diagnosis Characterisation of aptamer-anchored poly(EDMA-co-GMA) monolith for high throughput affinity binding Advancing Aptamers as Molecular Probes for Cancer Theranostic Applications-The Role of Molecular Dynamics Simulation Chapter 8 -Impedimetric Aptasensors Using Nanomaterials Chapter 3 -Biosensors for Rapid Detection of Breast Cancer Biomarkers Chapter 8 -Biosensor technologies based on nanomaterials Piezoelectric Immunosensor for SARS-Associated Coronavirus in Sputum Label-free electrochemical immunosensor for quick detection of anti-hantavirus antibody Simple and effective label free electrochemical immunosensor for Fig mosaic virus detection Photoluminescence immunosensor based on bovine leukemia virus proteins immobilized on the ZnO nanorods Molecular Dynamics Simulation for All Enhanced sampling techniques in molecular dynamics simulations of biological systems Faster protein folding using enhanced conformational sampling of molecular dynamics simulation Predicting the impacts of mutations on protein-ligand binding affinity based on molecular dynamics simulations and machine learning methods Molecular dynamics simulations: from structure function relationships to drug discovery Molecular dynamics simulations and novel drug discovery High-Performance Drug Discovery: Computational Screening by Combining Docking and Molecular Dynamics Simulations Inhibition of HBV replication by theophylline In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain) Antiviral and other bioactivities of pyrimidinones Pyrimidinones. 1. 2-Amino-5-halo-6-aryl-4(3H)-pyrimidinones. Interferon-inducing antiviral agents Significance and Biological Importance of Pyrimidine in the Microbial World The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold DeePMD-kit: A deep learning package for many-body potential energy representation and molecular dynamics Improving ion-sensitive field-effect transistor selectivity with backpropagation neural network Recruiting machine learning methods for molecular simulations of proteins Time-lagged autoencoders: Deep learning of slow collective variables for molecular kinetics Deep clustering of protein folding simulations Machine Learning of Coarse-Grained Molecular Dynamics Force Fields Machine Learning Force Field Parameters from Ab Initio Data On-the-fly machine learning force field generation: Application to melting points Molecular Dynamics with On-the-Fly Machine Learning of Quantum-Mechanical Forces Deep Potential Molecular Dynamics: A Scalable Model with the Accuracy of Quantum Mechanics Artificial intelligence and machine learning to fight COVID-19 Deep learning methods in protein structure prediction Improved protein structure prediction using potentials from deep learning Development and current status of the CHARMM force field for nucleic acids Electrostatics of nanosystems: Application to microtubules and the ribosome The authors wish to thank the SimCenter at UTC for their support to this work. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.